Cargando…
First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain
We present a case of a 24-year-old male patient who presented to our institution five days after receiving his first dose of Pfizer-BioNTech vaccine to rule out acute coronary syndrome due to chest pain along with troponin increase and ECG changes. Acute coronavirus disease 2019 (COVID-19) infection...
Autores principales: | Chachar, Tarique S, Yousif, Nooraldaem, Sulaibikh, Leena, Abdulqader, Fuad, Alqahtani, Manaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747994/ https://www.ncbi.nlm.nih.gov/pubmed/35028213 http://dx.doi.org/10.7759/cureus.20313 |
Ejemplares similares
-
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Myocarditis: case report
Publicado: (2022) -
Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
Publicado: (2022) -
COVID-19 Vaccine Pfizer BioNTech: Acute myocarditis: case report
Publicado: (2022) -
COVID-19 vaccine Pfizer BioNTech: Recurrence of acute myocarditis: case report
Publicado: (2021)